BPC-157
Predominantly animal · No established human dosing schedule
BPC-157 is an investigational peptide with mostly animal evidence. The reviewed sources do not establish a routine human SubQ dose. Predominantly animal · No established human dosing schedule.
Reviewed 2026-10-17. A source reference, not a personal treatment plan. Discuss treatment decisions with a qualified clinician.
Dose reference
| STUDY CONTEXT | Dose | Frequency | Context |
|---|---|---|---|
| Human dosing | Not established | No validated schedule | A dose in an animal injury model cannot set a human injection amount, frequency or cycle. Uncontrolled reports do not resolve that dosing gap. Source |
A dose in an animal injury model cannot set a human injection amount, frequency or cycle. Uncontrolled reports do not resolve that dosing gap.
Source context
The cited experiment concerns tissue repair in rabbits. Small human reports and trial registrations do not supply a validated subcutaneous regimen for tendon, gut or general recovery claims.
Reading the dose correctly
A dose in an animal injury model cannot set a human injection amount, frequency or cycle. Uncontrolled reports do not resolve that dosing gap.
Download the chart
Further reading
BPC-157 monograph on myPeptides
References
Why is there no numerical dose for BPC-157 on this card?
A dose in an animal injury model cannot set a human injection amount, frequency or cycle. Uncontrolled reports do not resolve that dosing gap.
Does a missing dose mean that no research exists?
This card describes predominantly animal. Evidence of a mechanism, a laboratory finding or an exposure does not by itself establish a useful and safe human treatment schedule. The monograph explains the distinction.